Quoin Pharmaceuticals Files 8-K on Financials
Ticker: QNRX · Form: 8-K · Filed: Mar 13, 2024 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, company-update
TL;DR
Quoin Pharma dropped an 8-K detailing financials - check it out.
AI Summary
Quoin Pharmaceuticals, Ltd. filed an 8-K on March 13, 2024, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd., is incorporated in Israel and has its principal executive offices in Ashburn, VA.
Why It Matters
This filing provides investors with crucial updates on Quoin Pharmaceuticals' financial health and operational performance, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediate, significant negative news.
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filer
- March 13, 2024 (date) — Date of Report
- Cellect Biotechnology Ltd. (company) — Former Company Name
- Cellect Biomed Ltd. (company) — Former Company Name
- Ashburn, VA (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific details are not provided in the header information.
When was Quoin Pharmaceuticals, Ltd. previously known by other names?
The company was formerly known as Cellect Biotechnology Ltd. (name change on July 21, 2016) and Cellect Biomed Ltd. (name change on April 6, 2016).
Where are Quoin Pharmaceuticals, Ltd.'s principal executive offices located?
The principal executive offices are located at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.
What is the Commission File Number for Quoin Pharmaceuticals, Ltd.?
The Commission File Number is 001-37846.
What is the SIC code for Quoin Pharmaceuticals, Ltd.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 544 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-03-13 16:52:34
Filing Documents
- tm248782d1_8k.htm (8-K) — 27KB
- tm248782d1_ex99-1.htm (EX-99.1) — 87KB
- 0001104659-24-033990.txt ( ) — 291KB
- qnrx-20240313.xsd (EX-101.SCH) — 3KB
- qnrx-20240313_lab.xml (EX-101.LAB) — 33KB
- qnrx-20240313_pre.xml (EX-101.PRE) — 22KB
- tm248782d1_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial
Item 2.02 Results of Operations and Financial Condition. On March 13, 2024, Quoin Pharmaceuticals Ltd. (the "Company") announced its fourth quarter and fiscal year 2023 financial results. A copy of the Company's press release is attached as Exhibit 99.1 hereto and incorporated by reference herein. The information set forth and incorporated by reference in this Item 2.02 shall not be deemed to be "filed" with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and the Company does not incorporate it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated March 13, 2024 104 Cover Page Interactive Data file (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Date: March 13, 2024 QUOIN PHARMACEUTICALS LTD. By: /s/ Gordon Dunn Name: Gordon Dunn Title: Chief Financial Officer